|
|
Paget's Disease of the Breast
National Organization for Rare Disorders, Inc.
Synonyms
- Paget's Disease of the Nipple
- Mammary Paget's Disease
- Paget's Disease of the Nipple and Areola
Disorder Subdivisions
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Extramammary Paget's Disease
- Eczema
- Bowen's Disease
- Malignant Melanoma
- .
General Discussion
Paget's disease of the breast is a rare form of breast cancer that almost exclusively occurs in women. However, rare cases have been recorded in which men have been affected. The condition was originally reported in 1874 by Sir James Paget, an English surgeon, who also described an unrelated skeletal condition known as Paget's disease of the bone. It is essential to note that these disorders are distinct disease entities that are medically unrelated.
Paget's disease of the breast is characterized by inflammatory, "eczema-like" changes of the nipple that may extend to involve the areola, which is the circular, darkened (pigmented) region of skin surrounding the nipple. Initial findings often include itching (pruritus), scaling, and crusting of and/or discharge from the nipple. In those with Paget's disease of the breast, distinctive tumor cells (known as Paget cells) are present within the outermost layer of skin (epidermis) of the nipple. In addition, the condition is often associated with an underlying malignancy (i.e., cancer) of the milk ducts (ductal carcinoma). The malignancy may be confined to cells lining the milk ducts (carcinoma in situ) or may have invaded surrounding tissue (infiltrating carcinoma). (The milk ducts [lactiferous ducts] are the channels that carry milk secreted by lobes of the breast to the nipple.) Paget's disease of the breast is thought to represent approximately two to four percent of breast cancers. .
Symptoms
Paget's disease of the breast is a malignant (cancerous) condition that initially appears as chronic, inflammatory, "eczema-like" changes of the nipple and adjacent areas. The term "cancer" refers to a group of diseases characterized by abnormal, uncontrolled cellular growth that invades surrounding tissues and may potentially spread (metastasize) to distant bodily tissues or organs via the bloodstream, the lymphatic system, or other means.
In individuals with Paget's disease of the breast, initial, characteristic skin changes may include the appearance of reddish (erythematous), scaling, crusting, and/or abnormally thickened skin patches (plaques) or lesions on the nipple that may extend to adjacent areas of the areola. Some affected individuals may also have abnormal discharge from the nipple. Additional symptoms and findings may include itching (pruritic) or burning sensations and/or oozing or bleeding of the affected area. According to reports in the medical literature, the condition usually affects one breast (unilateral). However, there have also been some cases in which both breasts were involved (bilateral).
Because initial skin changes may appear relatively "benign looking," many individuals with Paget's disease of the breast may initially tend to overlook such symptoms, attributing them to inflammatory skin conditions or infection. As a result, diagnosis may be delayed in such cases, often up to six months or more. Most with the condition eventually seek medical attention due to associated itching or burning sensations, soreness, or pain of the affected area.
Some individuals with Paget's disease of the breast may have additional symptoms or findings. For example, in some instances, the nipple may turn inward (retracted nipple). In addition, up to 45 percent or more of affected individuals may have a lump or mass that may be felt (palpated) below the nipple, whereas, in many others, non-invasive or invasive malignant cells are detected upon microscopic diagnostic evaluation. (For further information, please see the "Standard Therapies: Diagnosis" section below.) In individuals with Paget's disease of the breast, the underlying malignancy may be completely contained within the milk ducts (ductal carcinoma in situ) or may have invaded surrounding tissue, potentially spreading to lymph nodes under the arms (axillary lymph nodes) and other regions of the body (metastatic disease). The overall disease course may vary greatly from case to case, depending upon the nature and size of an underlying malignancy, whether a palpable breast tumor is present upon diagnosis, whether metastatic disease is present, specific treatment measures followed, and other possible factors. .
Causes
As mentioned above, Paget's disease of the breast is characterized by the presence of distinctive tumor cells, known as Paget cells, within the outermost layer of skin (epidermis) of the nipple that may extend to involve adjacent regions of the areola. Paget cells are relatively large, undifferentiated (anaplastic) tumor cells with a distinctive appearance as detected upon microscopic evaluation.
The specific relationship between Paget cells within the nipple and underlying breast cancer has been unclear. Some investigators have suggested that the presence of Paget cells represents a distinct disease process originating in the outer skin layer of the nipple. However, the most widely accepted theory indicates that nipple involvement occurs secondary to the extension or infiltration of cancerous (malignant) cells from an underlying breast tumor (neoplasm). Supportive evidence includes laboratory studies demonstrating that Paget cells and the underlying breast cancer share certain characteristics, thus appearing to originate from the same cell population. In addition, malignant cells have been shown to extend along breast ductal tissue from the underlying breast tumor to the nipple. Accordingly, many researchers have concluded that Paget cells appear to be derived from the lining (epithelium) of milk (lactiferous) ducts, invading and multiplying (proliferating) within the surface tissue (epidermis) of the nipple and adjacent areas of the areola.
As with other cancers, the exact underlying cause or causes of breast malignancy associated with Paget's disease remain unknown. Researchers speculate that genetic and immunologic abnormalities, environmental factors (e.g., exposure to ultraviolet rays, certain chemicals, ionizing radiation), diet, stress, and/or other factors may play contributing roles in causing specific types of cancer. Investigators at the National Cancer Institute and elsewhere are conducting ongoing basic research to learn more about the many factors that may result in cancer.
In individuals with cancer, including breast malignancies, tumor development results from abnormal changes in the structure of certain cells. The specific cause of such changes is unknown. However, current research suggests that abnormalities of DNA (deoxyribonucleic acid), which is the carrier of the body's genetic code, are the underlying basis of cellular malignant transformation. In many cases, these abnormal changes may appear to occur spontaneously for unknown reasons (sporadically).
Cells that undergo malignant transformation typically revert to a less specialized, more primitive form (anaplasia or loss of "differentiation"), meaning that they are no longer capable of performing their "intended," specialized functions within the tissue in question. Malignant cells pass their abnormal changes on to their "daughter" cells and typically grow and divide at an unusually rapid, uncontrolled rate. This uncontrolled cellular growth may eventually result in invasion of surrounding tissues, infiltration of regional lymph nodes, and spread of the malignancy (metastasis) via the bloodstream, the lymphatic circulation, or other means. .
Affected Populations
Paget's disease of the breast is a rare form of breast cancer that almost exclusively affects women. However, there have been rare cases in which the disorder has occurred in men. Paget's disease of the breast most commonly affects middle-aged individuals, primarily occurring between 50 to 60 years of age. It is thought to represent approximately two to four percent of breast cancers. .
Related Disorders
Symptoms of the following disorders may be similar to those of Paget's disease of the breast. Comparisons may be useful for a differential diagnosis:
Extramammary Paget's disease (EMPD) is characterized by the development of a reddish, scaling lesion that resembles that seen in Paget's disease of the breast but does not occur on the breasts. (The term "extramammary" refers to regions other than or outside of the breasts.) In those with EMPD, additional symptoms and findings may include itching, burning, pain, and/or bleeding of the affected area. EMPD often involves the female or male external genitals (e.g., vulva, glans penis) and/or the region around the anus (perianal region). EMPD of the vulva is associated with an underlying cancer (carcinoma) in about 30 percent of cases; involvement of the perianal area is associated with a distant or underlying carcinoma in up to approximately 73 percent of cases.
Eczema is a common inflammatory condition characterized by itching (pruritus) and redness (erythema) of upper skin layers (i.e., superficial dermatitis). The condition is also often associated with blistering or scabbing, scaling, oozing, crusting, and thickening of affected skin areas. There are multiple types of eczema that may result from various internal (endogenous) and/or external (exogenous) factors, including an excessive immune response to certain, usually environmental agents.
Bowen's disease is a localized skin malignancy (i.e., squamous cell carcinoma in situ) consisting of solitary or multiple, sharply defined, reddish brown skin patches that may be scaly and slightly thickened. It frequently resembles dermatitis or other inflammatory skin conditions and most often occurs on sun-exposed areas of the skin. (For more information on this disorder, choose "Bowen" as your search term in the Rare Disease Database.)
Malignant melanoma is a common form of skin cancer that originates in pigment-producing cells (melanocytes). Most malignant melanomas develop from existing moles, although they may sometimes originate as new, pigmented growths, particularly in sun-exposed areas of the skin. Malignant melanomas are considered highly invasive, often spreading (metastasizing) through the blood and lymph circulation to distant areas of the body. (For more information on this disorder, choose "malignant melanoma" as your search term in the Rare Disease Database.) .
Standard Therapies
Diagnosis Paget's disease of the breast is diagnosed based upon thorough clinical examination, identification of characteristic physical findings, a complete patient history, and a variety of specialized tests. These may include blood tests; mammography or specialized x-ray imaging of the breasts; microscopic evaluation of any nipple discharge for cancerous cells (cytologic smear); and/or surgical removal (biopsy) and microscopic examination of affected breast tissue.
Treatment The treatment of Paget's disease of the breast may vary, depending upon the nature, size, and invasiveness of an underlying breast malignancy and the presence or absence of metastatic disease. Treatment has traditionally included surgical removal of breast tissue, adjacent lymph nodes, and, in some cases, underlying muscles of the upper chest wall and other tissues (modified radical or radical mastectomy). However, evidence suggests that, in selected individuals without a palpable breast mass and negative mammograms--or in those with disease confined to the nipple and areola--surgical removal of the nipple and areola, possibly in combination with radiation therapy, may be an appropriate alternative to mastectomy; in other selected cases, recommended treatment may consist of radiation therapy alone. For such individuals, mastectomy may be reserved in case of local recurrences. Experts indicate that further research is necessary to determine the long-term effectiveness of such breast-conserving measures in selected individuals with Paget's disease of the breast.
In other cases, such as for those with larger or more invasive malignancies, recommended treatment may include mastectomy, possibly in combination with radiation or therapy with certain anticancer drugs (chemotherapy). Decisions concerning the most appropriate treatment measures must be based upon the specifics of each individual's case. .
Investigational Therapies
Research on breast cancer is ongoing at the National Cancer Institute and elsewhere. For information concerning investigational therapies and clinical trials, please consider contacting the organizations listed in the "Resources" section of this report below.
NORD does not promote, endorse, or encourage participation in any specific medical research study. This information is presented to further scientific understanding that could lead to the prevention, treatment, and/or cure of rare disorders. NORD recommends that anyone interested in participating in a clinical research program seek the advice or counsel of his or her own personal physician(s). .
References
TEXTBOOKS Beers MH, et al., eds. The Merck Manual. 17th ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999:1974, 1982-1983.
Raghaven D, et al., eds. Textbook of Uncommon Cancer. 2nd ed. West Sussex, England: John Wiley & Sons Ltd.; 1999:1585-1586, 2409.
DeVita VT, Jr., et al., eds. Cancer: Principles and Practice of Oncology. Philadelphia, PA: Lippincott-Raven Publishers; 1997:202-203.
JOURNAL ARTICLES Bodnar M, et al. Paget's disease of the male breast associated with intraductal carcinoma. J Am Acad Dermatol. 1999;40:829-831.
Kollmorgen DR, et al. Paget's disease of the breast: a 33-year experience. J Am Coll Surg. 1998;187:171-177.
Burke ET, et al. Paget disease of the breast: a pictorial essay. Radiographics. 1998;18:1459-1464.
Pierce LJ, et al. The conservative management of Paget's disease of the breast with radiotherapy. Cancer. 1997;80:1065-1072.
Edeiken S. Mammography in the symptomatic woman. Cancer. 1989;1:1412-1414.
Stockdale AD, et al. Radiotherapy for Paget's disease of the nipple: a conservative alternative. 1989;16:664-666.
Fourquet A, et al. Paget's disease of the nipple without detectable breast tumor: conservative management with radiation therapy. Int J Radiol Oncol Biol Phys. 1987;13:1463-1465.
Sanchez JA, et al. Paget's disease of the breast. Am Fam Physician. 1987;36:145-147.
Resources
National Women's Health Network
514 10th Street NW Suite 400 Washington, D.C. 20004 USA Tel: 2026287814 Fax: 2023471168 Email: nwhn@nwhn.org Internet: http://www.womenshealthnetwork.org
Skin Cancer Foundation
245 Fifth Avenue Suite 1403 New York, NY 10016 Fax: (212)725-5751 Tel: (800)754-6490 Email: info@skincancer.org Internet: http://www.skincancer.org
American Cancer Society, Inc.
1599 Clifton Road NE Atlanta, GA 30329 USA Tel: 4043203333 Tel: 8002272345 Internet: http://www.cancer.org
Breast Cancer Advisory Center
P.O. Box 334 Kensington, MD 20895
National Alliance of Breast Cancer Organizations
9 East 37th Street 10th Floor New York, NY 10016 USA Tel: 2128890606 Fax: 2126891213 Tel: 8888062226 Email: nabcoinfo@aol.com Internet: http://www.nabco.org
National Cancer Institute Physician Data Query (PDQ) Cancer Information Service
9000 Rockville Pike Bethesda, MD 20892 Tel: (800)422-6237 Internet: http://www.cancernet.nci.nih.gov/pdq.html
National Cancer Institute
6116 Executive Blvd, MSC 8322, Room 3036A Bethesda, MD 20892-8322 USA Tel: 3014353848 Tel: 8004226237 TDD: 8003328615 Internet: http://www.cancer.gov
Y-ME National Breast Cancer Organization
212 West Van Buren 4th Floor Chicago, IL 60607-3908 USA Tel: 3129868338 Fax: 3122948598 Tel: 8009868228 Email: info@y-me.org Internet: http://www.y-me.org
National Breast Cancer Coalition
1707 L Street Northwest Suite 1060 Washington, DC 20036 Tel: (202)296-7477 Fax: (202)265-6854 Tel: (800)622-2838 Email: pgoddard@natlbcc.org Internet: http://www.natlbcc.org
OncoLink: The University of Pennsylvania Cancer Center Resource
3400 Spruce Street 2 Donner Philadelphia, PA 19104-4283 USA Tel: 2153495445 Fax: 2153495445 Email: editors@oncolink.upenn.edu Internet: http://www.oncolink.upenn.edu
SHARE - Self-Help For Women With Breast or Ovarian Cancer
1501 Broadway Suite 704A New York, NY 10036 Tel: (212)719-0364 Fax: (212)869-3431 Internet: http://www.sharecancersupport.org
Canadian Breast Cancer Network
331 rue Cooper Street Suite 602 Ottawa Ontario, Intl K2P 0G5 Canada Tel: 6137883311 Fax: 6132331056 Tel: 8006858820 Email: cbcn@cbcn.ca Internet: http://www.cbcn.ca
Breast Cancer Society of Canada
401 St. Clair Street Point Edward Ontario, N7V 1P2 Canada Tel: 5193360746 Fax: 5193365725 Email: bcsc@bcsc.ca Internet: http://www.bcsc.ca
Friends of Cancer Research
2231 Crystal Drive Suite 200 Arlington, VA 22202 Tel: (703)302-1503 Fax: (703)302-1568 Email: info@focr.org Internet: http://www.focr.org
Wellness Community
919 18th Street N.W. Suite 54 Washington, DC 20006 Tel: (202)659-9709 Fax: (202)659-9301 Tel: (888)793-9355 Email: help@thewellnesscommunity.org Internet: http://www.thewellnesscommunity.org
Lance Armstrong Foundation
PO Box 161550 Austin, TX 78716-1150 Tel: (512)236-8820 Fax: (512)236-8482 Tel: (866)235-7205 Internet: http://www.livestrong.org
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for
informational purposes only. NORD recommends that affected individuals seek the advice or counsel of
their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms
listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the
topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease
Database completely current and accurate. Please check with the agencies listed in the Resources section
for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization
for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site
www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 9/1/2000
Copyright 1990, 2000
National Organization for Rare Disorders, Inc.
|
|
|
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
|
|